VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$515.44
arrow_upward
+0.17%(+0.88) 1D
$514.51
arrow_downward
-0.18% (-0.93)bedtimeAfter hours
Closed: Sep 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$522.10
High
$522.10
Low
$511.81
Mkt. cap
130.64B
Avg. vol.
1.15M
Volume
875.64K
P/E ratio
29.99
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
Open
$522.10
High
$522.10
Low
$511.81
Mkt. cap
130.64B
Avg. vol.
1.15M
Volume
875.64K
P/E ratio
29.99
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance
·
16 hours ago
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference
Yahoo Finance
·
1 day ago
Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis
Yahoo! Finance Canada
·
1 day ago
Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com